Case Report
BibTex RIS Cite

Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria

Year 2020, Volume: 10 Issue: 04, 222 - 224, 15.12.2020
https://doi.org/10.5799/jmid.839476

Abstract

We describe the emergence of plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19. The strain was isolated from a urine sample of a 75-year-old male patient. The identification was carried out by an automated system. The antibiogram was performed according to CLSI recommendations. The colistin MIC was determined by broth micro-dilution according to CA-SFM/EUCAST criteria. The detection of mcr-1 was carried out by immunochromatographic test and PCR mcr-1. Genetic transfers and determination of the plasmid incompatibility group were made. The ST was carried out by MLST using the Pasteur scheme.
The strain has a high-level penicillinase resistance phenotype. It was susceptible to amikacin and resistant to gentamicin, tobramycin, fluoroquinolones, tetracycline, chloramphenicol, and cotrimoxazole. The strain was resistant to colistin (MIC ꞊ 4 μg/ml).
The genetic transfer is given a colistin-resistant transconjugant. The plasmid carrying mcr-1 gene belongs to the incompatibility group IncHI2.The strain belongs to ST19. J Microbiol Infect Dis 2019; 10(4):222-224.

References

  • 1. Liu Y-Y, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. The Lancet Infectious Diseases. févr 2016;16(2):161‑8.
  • 2. Dortet L, Bonnin R, Jousset A, Gauthier L, Naas T. Émergence de la résistance à la colistine chez les entérobactéries : une brèche dans le dernier rempart contre la pan-résistance ! Journal des Anti-infectieux. déc 2016;18(4):139‑59.
  • 3. CLSI. Performance standards for Antimicrobial Susceptibility testing. 28th ed. CLSI supplement M100.Wayne, PA: Clinical and Laboratory Standard Institute; 2018. (ISBN: 1-56238-839-8)
  • 4. Enterobacteriaceae. In: CASFM / EUCAST: Société Française de Microbiologie Ed; 2018: p.36-43.
  • 5. Chabou S, Leangapichart T, Okdah L, Le Page S, Hadjadj L, Rolain J-M. Real-time quantitative PCR assay with Taqman ® probe for rapid detection of MCR-1 plasmid-mediated colistin resistance. N Microb N Infect 2016; 13:71‑4.
  • 6. Jaureguy F, Landraud L, Passet V, et al. Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains. BMC Genomics 2008;9 (1):560.
  • 7. Bachiri T, Lalaoui R, Bakour S, et al. First Report of the Plasmid-Mediated Colistin Resistance Gene mcr-1 in Escherichia coli ST405 Isolated from Wildlife in Bejaia, Algeria. Microbial Drug Resist 2018; 24(7):890‑5.
  • 8. Yanat B, Machuca J, Yahia RD, Touati A, Pascual Á, Rodríguez-Martínez J-M. First report of the plasmid-mediated colistin resistance gene mcr-1 in a clinical Escherichia coli isolate in Algeria. Intern J Antimicrob Agent 2016;48(6):760‑1.
  • 9. Berrazeg M, Hadjadj L, Ayad A, Drissi M, Rolain J-M. First Detected Human Case in Algeria of mcr-1 Plasmid-Mediated Colistin Resistance in a 2011 Escherichia coli Isolate. Antimicrob Agent Chemother 2016; 60(11):6996‑7.
  • 10. Delgado-Blas JF, Ovejero CM, Abadia-Patiño L, Gonzalez-Zorn B. Coexistence of mcr-1 and bla NDM-1 in Escherichia coli from Venezuela. Antimicrob Agents Chemother 2016; 60(10):6356‑8.
  • 11. Rossi F, Girardello R, Morais C, et al. Plasmid-mediated mcr-1 in carbapenem-susceptible Escherichia coli ST156 causing a blood infection: an unnoticeable spread of colistin resistance in Brazil? Case Reports: Clinics (Sao Paulo) 2017; 72(10):642‑4.
  • 12. Yang R-S, Feng Y, Lv X-Y, et al. Emergence of NDM-5- and MCR-1-Producing Escherichia coli Clones ST648 and ST156 from a Single Muscovy Duck (Cairina moschata). Antimicrob Agents Chemother 2016; 60(11):6899‑902.
  • 13. Bernasconi OJ, Kuenzli E, Pires J, et al. Travelers Can Import Colistin-Resistant Enterobacteriaceae, Including Those Possessing the Plasmid-Mediated mcr-1 Gene. Antimicrob Agents Chemother 2016; 60(8):5080‑4.
  • 14. Doumith M, Godbole G, Ashton P, et al. Detection of the plasmid-mediated mcr-1 gene conferring colistin resistance in human and food isolates of Salmonella enterica and Escherichia coli in England and Wales. J Antimicrob Chemother 2016; 71(8):2300‑5.
Year 2020, Volume: 10 Issue: 04, 222 - 224, 15.12.2020
https://doi.org/10.5799/jmid.839476

Abstract

References

  • 1. Liu Y-Y, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. The Lancet Infectious Diseases. févr 2016;16(2):161‑8.
  • 2. Dortet L, Bonnin R, Jousset A, Gauthier L, Naas T. Émergence de la résistance à la colistine chez les entérobactéries : une brèche dans le dernier rempart contre la pan-résistance ! Journal des Anti-infectieux. déc 2016;18(4):139‑59.
  • 3. CLSI. Performance standards for Antimicrobial Susceptibility testing. 28th ed. CLSI supplement M100.Wayne, PA: Clinical and Laboratory Standard Institute; 2018. (ISBN: 1-56238-839-8)
  • 4. Enterobacteriaceae. In: CASFM / EUCAST: Société Française de Microbiologie Ed; 2018: p.36-43.
  • 5. Chabou S, Leangapichart T, Okdah L, Le Page S, Hadjadj L, Rolain J-M. Real-time quantitative PCR assay with Taqman ® probe for rapid detection of MCR-1 plasmid-mediated colistin resistance. N Microb N Infect 2016; 13:71‑4.
  • 6. Jaureguy F, Landraud L, Passet V, et al. Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains. BMC Genomics 2008;9 (1):560.
  • 7. Bachiri T, Lalaoui R, Bakour S, et al. First Report of the Plasmid-Mediated Colistin Resistance Gene mcr-1 in Escherichia coli ST405 Isolated from Wildlife in Bejaia, Algeria. Microbial Drug Resist 2018; 24(7):890‑5.
  • 8. Yanat B, Machuca J, Yahia RD, Touati A, Pascual Á, Rodríguez-Martínez J-M. First report of the plasmid-mediated colistin resistance gene mcr-1 in a clinical Escherichia coli isolate in Algeria. Intern J Antimicrob Agent 2016;48(6):760‑1.
  • 9. Berrazeg M, Hadjadj L, Ayad A, Drissi M, Rolain J-M. First Detected Human Case in Algeria of mcr-1 Plasmid-Mediated Colistin Resistance in a 2011 Escherichia coli Isolate. Antimicrob Agent Chemother 2016; 60(11):6996‑7.
  • 10. Delgado-Blas JF, Ovejero CM, Abadia-Patiño L, Gonzalez-Zorn B. Coexistence of mcr-1 and bla NDM-1 in Escherichia coli from Venezuela. Antimicrob Agents Chemother 2016; 60(10):6356‑8.
  • 11. Rossi F, Girardello R, Morais C, et al. Plasmid-mediated mcr-1 in carbapenem-susceptible Escherichia coli ST156 causing a blood infection: an unnoticeable spread of colistin resistance in Brazil? Case Reports: Clinics (Sao Paulo) 2017; 72(10):642‑4.
  • 12. Yang R-S, Feng Y, Lv X-Y, et al. Emergence of NDM-5- and MCR-1-Producing Escherichia coli Clones ST648 and ST156 from a Single Muscovy Duck (Cairina moschata). Antimicrob Agents Chemother 2016; 60(11):6899‑902.
  • 13. Bernasconi OJ, Kuenzli E, Pires J, et al. Travelers Can Import Colistin-Resistant Enterobacteriaceae, Including Those Possessing the Plasmid-Mediated mcr-1 Gene. Antimicrob Agents Chemother 2016; 60(8):5080‑4.
  • 14. Doumith M, Godbole G, Ashton P, et al. Detection of the plasmid-mediated mcr-1 gene conferring colistin resistance in human and food isolates of Salmonella enterica and Escherichia coli in England and Wales. J Antimicrob Chemother 2016; 71(8):2300‑5.
There are 14 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Case Report
Authors

Selma Bouheraoua This is me

Farida Assaous This is me

Nora Zourdani This is me

Naima Tahrat This is me

Hassiba Tali Maamar This is me

Publication Date December 15, 2020
Published in Issue Year 2020 Volume: 10 Issue: 04

Cite

APA Bouheraoua, S., Assaous, F., Zourdani, N., Tahrat, N., et al. (2020). Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria. Journal of Microbiology and Infectious Diseases, 10(04), 222-224. https://doi.org/10.5799/jmid.839476
AMA Bouheraoua S, Assaous F, Zourdani N, Tahrat N, Maamar HT. Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria. J Microbil Infect Dis. December 2020;10(04):222-224. doi:10.5799/jmid.839476
Chicago Bouheraoua, Selma, Farida Assaous, Nora Zourdani, Naima Tahrat, and Hassiba Tali Maamar. “Plasmid-Mediated Colistin Resistance Mcr-1 in a Clinical Isolate of Escherichia Coli ST19 in Algeria”. Journal of Microbiology and Infectious Diseases 10, no. 04 (December 2020): 222-24. https://doi.org/10.5799/jmid.839476.
EndNote Bouheraoua S, Assaous F, Zourdani N, Tahrat N, Maamar HT (December 1, 2020) Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria. Journal of Microbiology and Infectious Diseases 10 04 222–224.
IEEE S. Bouheraoua, F. Assaous, N. Zourdani, N. Tahrat, and H. T. Maamar, “Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria”, J Microbil Infect Dis, vol. 10, no. 04, pp. 222–224, 2020, doi: 10.5799/jmid.839476.
ISNAD Bouheraoua, Selma et al. “Plasmid-Mediated Colistin Resistance Mcr-1 in a Clinical Isolate of Escherichia Coli ST19 in Algeria”. Journal of Microbiology and Infectious Diseases 10/04 (December 2020), 222-224. https://doi.org/10.5799/jmid.839476.
JAMA Bouheraoua S, Assaous F, Zourdani N, Tahrat N, Maamar HT. Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria. J Microbil Infect Dis. 2020;10:222–224.
MLA Bouheraoua, Selma et al. “Plasmid-Mediated Colistin Resistance Mcr-1 in a Clinical Isolate of Escherichia Coli ST19 in Algeria”. Journal of Microbiology and Infectious Diseases, vol. 10, no. 04, 2020, pp. 222-4, doi:10.5799/jmid.839476.
Vancouver Bouheraoua S, Assaous F, Zourdani N, Tahrat N, Maamar HT. Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria. J Microbil Infect Dis. 2020;10(04):222-4.